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OCT-Veriﬁed Neointimal Hyperplasia
Is Increased at Fracture Site in Drug-
Eluting Stents
Although drug-eluting stents dramatically reduce stent resteno-
sis, in-stent restenosis still occurs in approximately 10% of
sirolimus-eluting stent (SES) implantation cases. Optical coher-
ence tomography (OCT) has the potential to assess neointima
hyperplasia precisely in vivo (1). However, the morphological
eatures of stent fracture in OCT imaging have not yet been
eported, and there is no OCT study that clarifies the relation-
hip between stent fracture and neointimal hyperplasia in SES.
e investigated the morphological features of stent fracture in
CT to clarify the relationship between stent fracture and
eointimal hyperplasia in SES.
Figure 1. An Exactly Matching Set Among Angiography, Fluoroscopy
A nonfractured stent shows (A) no restenosis in angiography, (B) no disto
(D) well-covered stent struts (yellow circle) in optical coherence tomogra
restenosis in angiography, (G) distorted and fractured stent in ﬂuoroscop
(white line) at fractured site in OCT. (H, J) A substitute stent area that is
(yellow circle) is applied for neointimal area assessment at fractured site.We enrolled 110 adequately expanded SES (BxVelocity plat-
orm) stents from 70 patients. For overlapped stents
n  41), we confirmed complete overlapping in the post-
rocedural angiography. The scheduled coronary angiography
nd OCT imaging were performed at 11  6 months after SES
mplantation. According to the presence of stent fracture in
reath-hold fluoroscopy, stents were divided into a fractured
tent group and a nonfractured stent group. Binary restenosis
as defined as a 50% stenosis by the CMS-QCA system
CMS-MEDIS, Medical Imaging Systems, Leiden, the Neth-
rlands). An OCT 0.016-inch catheter (ImageWire, LightLab
maging, Westford, Massachusetts) was used, and all OCT
mage acquisitions were performed with the continuous-flushing
ethod (2). To coregister OCT images and coronary angio-
rams on an individual stent basis, we used the distance from
ach stent edge, the tip of guiding catheter, and anatomical
andmarks. Stent area, lumen area, and neointima area were
easured according to a previous report (3). In case stent struts
cannot be recognized, substitute stent area, which was an average
stent area of both broken edges of the fractured stent, was applied (Fig.
1). Neointimal area was assessed in multiple slices, incrementally
spaced by 1 mm from fracture site to distal and proximal sites.
To assess the distribution pattern of neointima within the stent,
neointimal hyperplasia was repartitioned along the stent length
into 18 segments.
Stent fracture was observed in 14 (12.7%) of 110 stents. The
fractured stent group showed higher binary in-stent restenosis
(29% vs. 6%, p  0.02) and percent diameter stenosis (44.8 
d OCT
stent in ﬂuoroscopy, (C) preserved coronary lumen (white circle), and
(OCT). (C–E) Neointima grows evenly. A fractured stent shows (F) focal
d (I) excessive neointimal hyperplasia with absence of stent struts
average stent area of both broken edges of the fractured stent, an
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Letters to the Editor 23328.0% vs. 14.9  23.6%, p  0.01) compared with the
nonfractured stent group. The absence of stent strut was the
common morphological feature of stent fracture in OCT. Both
mean and maximal neointimal area were larger in the stent
fracture group (fracture 1.59  0.75 mm2 vs. nonfracture 0.55 
.46 mm2, p  0.01; and fracture 3.30  1.73 mm2 vs.
nonfracture 1.28  1.10 mm2, p  0.01, respectively). Although
neointima grew equally in the nonfractured stent group, the
distribution of neointimal area showed a peak at the fracture site
in the fractured stent group (Fig. 2). The longitudinal length of
the absence of stent struts was positively correlated with the
neointimal area at the fracture site (r  0.79, p  0.01). From
the receiver-operating characteristics curve, the best cutoff value
of the length of the absence of stent struts to diagnose stent
fracture was 1.07 mm (area under the curve 0.85, sensitivity 93%,
and specificity 80%).
The absence of stent strut was the common morphological
feature of stent fracture, and its length was correlated with the
neointimal area. These results suggest that the loss of stent strut
itself is one of the important contributors to excessive neointimal
growth. Previous ex vivo studies reported that cyclic stretch on
cultured cells induces the proliferation of vascular smooth
muscle cells. We have reported that stent fracture frequently
occurs at bend lesions (4). When stent fracture occurs, the stent
loses its ability to scaffold the artery wall against mechanical
stress. We speculate that occurrence of these mechanical stresses
at the fracture site could contribute to excessive neointimal
growth. Furthermore, many previous studies have postulated
other causes for SES restenosis including stent under-expansion,
polymer disruption, stent strut inconsistent distribution, and
stent fracture. These factors could directly or indirectly affect the
drug delivery. Even though it is difficult to know when the stent
was fractured, we speculate that a loss of stent struts at the
fracture site may impede effective local drug delivery, resulting in
Figure 2. Neointimal Hyperplasia Area and Distance From the
Fracture Site
The distribution of neointimal hyperplasia shows a peak at the fracture site.
Data are shown as mean with SD.failure to prevent the neointimal growth. cThis study has several limitations. We only analyzed a small
number of fractured stents. Fluoroscopy might miss small stent
fractures because of its low spatial resolution. Thrombus or lipid
components may disturb the accurate assessment of neointima
area. There is also a possibility that stent struts covered with
thick neointima may be misdiagnosed as the disappearance of
stent struts. In conclusion, OCT could diagnose stent fracture,
and neointimal hyperplasia is enhanced at the fracture site.
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T2-Weighted CMR
But Where Is Elvis in the End?
A few months ago, in an editorial by Raman et al. (1), T2-weighted
(T2w) short tau inversion recovery (STIR) imaging, the only
alidated T2 sequence that was tested against pathology in an
experimental setting to assess the myocardial area at risk (AAR),
was almost thrown out the window because of its limited accuracy
and poor reproducibility due to the high sensitivity to artifacts.
However, there was still hope, because better sequences have come
out (T2w ACUTE [Acquisition for Cardiac Unified T2 Edema],
T2prep steady-state free precession, T2 mapping) with significantly
etter reproducibility and accuracy. But those sequences have not
een validated against pathology.
In a recent issue of iJACC, Fuernau and Eitel et al. (2) have
ublished successively several papers about large groups of acute
T-segment elevation myocardial infarction patients in whom
2wSTIR was used to assess the AAR. Their results showed that
2wSTIR had a significant prognostic value, and it was well
orrelated to angiographic surrogates of the myocardial AAR. At
